They also help the pancreas release insulin when blood sugar levels are high
Adding the Precision Peptide Genetic Test after your first month of treatment is $298 and provides data-driven guidance on whether semaglutide alone, a dual compound like GLP-Squared, or dosing adjustments will best match your genetic hormone profile
[1] In phase 3 trials, orforglipron produced 12.4% weight loss (27.3 lbs) at 72 weeks less than injectable tirzepatide (20%) but comparable to oral semaglutide
Compare the PlexusDx route: review the Weight Management Protocols, which pair semaglutide and tirzepatide with genetic context most telehealth-only programs leave out
3 Because postprandial hyperglycemia affects A1C to a greater degree than fasting hyperglycemia, the closer a patient is to the A1C goal, GLP-1 receptor agonists provide a viable treatment option to target postprandial glucose excursions due to their glucose-dependent effects on insulin secretion
This equalizes the pressure and makes drawing the liquid out much, much easier